This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignees: Taiho Pharmaceutical Company Limited, Banyu Pharmaceutical Co. Ltd, Msd K.k.. Active years: 2007-2019.
Company Filing History:
5 out of 320 
4 out of 237 
2 out of 47 
Years Active: 2007-2019
Title: The Innovative Contributions of Takeshi Sagara
Introduction
Takeshi Sagara is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific cancer-related pathways. With a total of 11 patents to his name, Sagara's work is recognized for its potential impact on cancer treatment.
Latest Patents
Among his latest patents is a novel Pyrazolo[3,4-d]pyrimidine compound or salt thereof. This compound is designed to exhibit a HER2 inhibitory effect, which is crucial for developing medicaments aimed at preventing and treating diseases involving HER2, especially cancer. The invention provides a compound of formula (I), where specific variables are defined in the patent specification, or a salt thereof.
Career Highlights
Sagara has worked with notable companies in the pharmaceutical industry, including Taiho Pharmaceutical Company Limited and Banyu Pharmaceutical Co. Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Throughout his career, Sagara has collaborated with talented individuals such as Sachie Otsuki and Hiroshi Hirai. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Takeshi Sagara's innovative work in the pharmaceutical field, particularly his